AfzeliusB. A.EwetzL.PalmbladJ.UdenA. M.VenizolesN., 1980. Structure and function of neutrophil leukocytes from patients with immotile-cilia syndrome. Acta Med. Scand.208:145.
2.
AmesB.1983. Dietary carcinogens and anticarcinogens: Oxygen radicals and degenerative disease. Science, 221:1256.
3.
BabiorD. M.KipnessR. S.CurnutteJ. I., 1973. Biological defence mechanism: The production by leukocytes of superoxide, a potential bactericidial agent. J. Clin. Invest., 52:741.
4.
BaggioliniM.DewaldB., 1985. The Neutrophil. Int. Archs Allergy appl. Immun., 76:13.
CraddockP. R.HammerschmidtD.WhiteJ. G.DalmassoA. P.JacobH. S., 1977. Complement (C5a)-induced granulocyte aggregation in vitro. J. Clin. Invest., 60:260.
7.
CrossC. E.1987. Oxygen Radicals and Human Disease. Ann. Int. Med., 107: 526.
8.
EmeritI.1986. Oxygen-derived free radicals and DNA damage in autoimmune diseases. In: Free Radicals, Aging, and Degenerative Diseases (JohnsonJ. E.JrWalfordR.HarmonD.MiguelJ. eds.), New York: Alan R. Liss, Inc., 307.
9.
GallinJ. I.WrightD. G.MalechH. L.DavisJ. M.KlempnerM. S.KikpatrickC. H., 1980. Disorders of chemotaxis. Ann. Int. Med., 92:520.
10.
GoetzlE. J.GoldsteinI. M., 1985. Cellular components of inflammation: Granulocytes. In: Textbook of rheumatology (KelleyW. N.HarrisE. D.RuddyS.SledgeC. B., eds.), pp. 115–144. Pbl. by W. B. Saunders Company, Philadelphia.
11.
KlebanoffS. J.1980. Oxygen metabolism and the toxic properties of phagocytes. Ann. Int. Med., 93:480.
KozumboW. J.TrushM. A.KenslerT. W., 1985. Are free radicals involved in tumor promotion?, Chem. Biol. Interact., 54:199.
14.
JohnsonJ. E.JrWalfordR.HarmonD.MiguelJ., eds., Free radicals, Aging, and Degenerative Diseases, New York: Alan R. Liss, Inc.1986.
15.
MalechH. L.RootR. K.GallinJ. I., 1977. Structural analysis of human neutrophil migration. J. Cell. Biol., 75:666.
16.
MarshallP. J.LandsW. E. M., 1986. In vitro formation of activators for prostaglandin synthesis by neutrophils and macrophages from humans and guinea pigs. J. Lab. Clin. Med., 108:525.
17.
MauriC.RizzoS. C.RicevutiG., eds. 1987. The Biology of Phagocytes in Health and Disease, “Advances in biosciences” series, vol. 66, Pergamon Press., Oxford.
18.
MazzoneA.1985. Produzione di anione superossido da blasti leucemici. Medicina Riv. E.M.I., 5:197.
19.
MazzoneA.RicevutiG.RossiM.RizzoS. C., 1986. The probable role of superoxide produced by blast cells in leukaemic cuteneous spreading. Int. J. Tiss. Reac., VIII: 493.
20.
MazzoneA.RicevutiG.RossiM.RizzoS. C., 1986. Prognostic significance of functional defects of granulocytes in myeloproliferative disease. Oncology, 43:176.
21.
McCordJ. M.DayE. D.Jr, 1987. Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett., 86:139.
22.
McCordJ. M.1985. Oxygen-derived free radicals in postichemic tissue injury. N. Engl. J. Med., 312:159.
23.
NathahC. F.SilversteinS. C.BruknerL. H.CohnQ. A., 1979. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J. Exp. Med., 149:100.
24.
O'FlahertyJ. T.DechateletL. R.McCallC. E.BassD. A., 1980. Neutrophil aggregation: Evidence for a different mechanism of action by phorbol-myristate-acetate (40962). Proc. soc. Exp. Biol. Med., 165:225.
25.
RicevutiG.MazzoneA.RicevutiG. P.RossiM. L.RossiniS., 1984. Cytochemical and skin window studies in polycytemia rubra vera. J. Clin. Hemat. Oncol., 14:45.
26.
RicevutiG.MazzoneA., 1987. Clinical aspects of neutrophil locomotion disorders. Biomedicine and Pharmacotherapy, 41: 355.
27.
RicevutiG.MazzoneA.RizzoS. C., 1986. A study of neutrophil function in a case of associated autoimmune neutropenia and trombocytemia treated with high doses of intravenous gammaglobulin (HDIGG). Clin. Lab. Haemat., 8:325.
28.
Roch-ArveillerM.Pham-HuyD.MuntanerO.MamanL.GiroudJ. P., 1987. Drug activity in vitro and in vivo on leucocyte chemotaxis. Biomedicine and Pharmacotherapy, 41:321.
29.
Roch-AvelierM.PerianinA.Pham-HuyD.GiroudJ. P., 1985. Modifications of neutrophil chemotactic responsiveness during various inflammatory reactions. Pathol. Res. Pract., 180:130.
30.
SamuelssonB.1983. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science, 220:568.
31.
SedorJ. R.1986. Free radicals and prostanoid synthesis. J. Lab. Clin. Med., 108:521.
32.
SimpsonP. J.MitsosS. E.VenturaA.GallagherK. P.FantoneJ. C.AbramsG. D.SchrkM. A.LucchesiB. R., 1987. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am. Heart J., 113:129.
33.
SolomonS. S.PalazzoloM., 1986. Activation of cyclic AMP phosphodiesterase by phorbol and protein kinase C pathway. Am. J. Med. Sci, 292:182.
34.
ThompsonJ. A.HessM. L., 1986. The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Prog. Cardiovasc. Dis., 28:449.
35.
TrollW.WiesnerR., 1985. The role of oxygen radicals as a possible mechanism of tumor promotion. Ann. Rev. Pharmacol Toxicol, 25:509.
36.
WilsonE.LasterS. M.GoodingL. R.LambethJ. D., 1987. Platelet-derived growth factor stimulates phagocytosis and blocks agonist-induced activation of the neutrophil oxidative burst: A possible cellular mechanism to protect oxygen radical damage. Proc. Natl. Acad. Sci., 84:2213.
